- Home
- URG vs VERV Comparison
URG vs VERV Comparison
Compare URG & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- URG
- VERV
- Stock Information
- Founded
- URG 2004
- VERV 2018
- Country
- URG United States
- VERV United States
- Employees
- URG N/A
- VERV N/A
- Industry
- URG Precious Metals
- VERV Medicinal Chemicals and Botanical Products
- Sector
- URG Basic Materials
- VERV Health Care
- Exchange
- URG Nasdaq
- VERV Nasdaq
- Market Cap
- URG 458.8M
- VERV 475.0M
- IPO Year
- URG N/A
- VERV 2021
- Fundamental
- Price
- URG $1.12
- VERV $6.57
- Analyst Decision
- URG Strong Buy
- VERV Strong Buy
- Analyst Count
- URG 2
- VERV 4
- Target Price
- URG $2.45
- VERV $25.75
- AVG Volume (30 Days)
- URG 3.6M
- VERV 1.4M
- Earning Date
- URG 03-05-2025
- VERV 02-25-2025
- Dividend Yield
- URG N/A
- VERV N/A
- EPS Growth
- URG N/A
- VERV N/A
- EPS
- URG N/A
- VERV N/A
- Revenue
- URG $16,494,000.00
- VERV $24,396,000.00
- Revenue This Year
- URG $86.92
- VERV $97.47
- Revenue Next Year
- URG $73.30
- VERV N/A
- P/E Ratio
- URG N/A
- VERV N/A
- Revenue Growth
- URG 34.78
- VERV 219.91
- 52 Week Low
- URG $0.96
- VERV $4.31
- 52 Week High
- URG $2.01
- VERV $19.34
- Technical
- Relative Strength Index (RSI)
- URG 42.34
- VERV 58.47
- Support Level
- URG $1.08
- VERV $5.32
- Resistance Level
- URG $1.19
- VERV $6.87
- Average True Range (ATR)
- URG 0.06
- VERV 0.53
- MACD
- URG -0.00
- VERV 0.05
- Stochastic Oscillator
- URG 17.50
- VERV 80.71
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is y is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.